EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decoding ribosome complexity: role of ribosomal proteins in cancer and disease

Pedro Fuentes, Joffrey Pelletier, Antonio Gentilella iD

NAR Cancer · 09.07.2024 · 6 (3)

DOI: 10.1093/narcan/zcae032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 23.07.2024. Verfasst von Pedro Fuentes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Metabolism, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llpbregat, Barcelona, Sp…. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, Associación Española Contra el Cancer, Agency for Management of University and Research Grants.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ribosome is a remarkably complex machinery, at the interface with diverse cellular functions and processes. Evolutionarily conserved, yet intricately regulated, ribosomes play pivotal roles in decoding genetic information into the synthesis of proteins and in the generation of biomass critical for cellular physiological functions. Recent insights have revealed the existence of ribosome heterogeneity at multiple levels. Such heterogeneity extends to cancer, where aberrant ribosome biogenesis and function contribute to oncogenesis. This led to the emergence of the concept of ‘onco-ribosomes’, specific ribosomal variants with altered structural dynamics, contributing to cancer initiation and progression. Ribosomal proteins (RPs) are involved in many of these alterations, acting as critical factors for the translational reprogramming of cancer cells. In this review article, we highlight the roles of RPs in ribosome biogenesis, how mutations in RPs and their paralogues reshape the translational landscape, driving clonal evolution and therapeutic resistance. Furthermore, we present recent evidence providing new insights into post-translational modifications of RPs, such as ubiquitylation, UFMylation and phosphorylation, and how they regulate ribosome recycling, translational fidelity and cellular stress responses. Understanding the intricate interplay between ribosome complexity, heterogeneity and RP-mediated regulatory mechanisms in pathology offers profound insights into cancer biology and unveils novel therapeutic avenues targeting the translational machinery in cancer.

Autor:innen und Institutionen

  • Laboratory of Cancer Metabolism, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llpbregat, Barcelona, Spain.
  • Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, 08908, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, 08028, Barcelona, Spain.

ORCID-Profile: Antonio Gentilella

Förderung

  • Agencia Estatal de Investigación
  • Associación Española Contra el Cancer
  • Agency for Management of University and Research Grants

Zitieren

APA

Fuentes, P., Pelletier, J., & Gentilella, A. (2024). Decoding ribosome complexity: role of ribosomal proteins in cancer and disease. NAR Cancer, 6(3). https://doi.org/10.1093/narcan/zcae032

Vancouver

Fuentes P, Pelletier J, Gentilella A. Decoding ribosome complexity: role of ribosomal proteins in cancer and disease. NAR Cancer. 2024;6(3). doi:10.1093/narcan/zcae032

BibTeX
@article{Fuentes2024,
  author = {Fuentes, Pedro and Pelletier, Joffrey and Gentilella, Antonio},
  title = {Decoding ribosome complexity: role of ribosomal proteins in cancer and disease},
  journal = {NAR Cancer},
  year = {2024},
  volume = {6},
  number = {3},
  doi = {10.1093/narcan/zcae032}
}
Kostenlos starten →